Decibel Therapeutics, Inc. DBTX
Set alert
4.91 +4.91 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 80.55M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -1.72
- Beta
- -0.15
- Short ratio
- 4.96
- Inst. own
- 70.72%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 8, 2023
- 50-d avg
- 3.93
- 200-d avg
- 3.40
- 1y target
- 14.40
Financial health
Altman Z-Score
-4.29 Distress zone
Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.
Piotroski F-Score
2 / 9 Weak
Nine pass/fail tests of profitability, leverage and efficiency.
Valuation
P/E -0.8×
FY 2018 5y median -3.2× FY 2022
P/S 0.0×
FY 2018 5y median 0.0× FY 2022
P/B 0.6×
FY 2018 5y median 0.7× FY 2022
P/FCF -0.9×
FY 2018 5y median -2.6× FY 2022
EV/EBITDA -0.5×
FY 2018 5y median -2.7× FY 2022
EV/Sales 0.0×
FY 2018 5y median 0.0× FY 2022
FCF Yield -112.1%
FY 2018 5y median -37.8% FY 2022
Profitability
Gross Margin 0.0%
FY 2018 5y median 0.0% FY 2022
Operating Margin 0.0%
FY 2018 5y median 0.0% FY 2022
Net Margin 0.0%
FY 2018 5y median 0.0% FY 2022
ROE -77.0%
FY 2018 5y median -62.9% FY 2022
ROIC -61.2%
FY 2018 5y median -61.2% FY 2022
ROA -51.1%
FY 2018 5y median -51.1% FY 2022
Growth (YoY)
Revenue 0.0%
FY 2018 FY 2022
Operating Income -27.3%
FY 2018 FY 2022
EPS (diluted) -5.9%
FY 2018 FY 2022
Free Cash Flow -30.7%
FY 2018 FY 2022
Financial Health
Current Ratio 4.8×
FY 2018 5y median 4.8× FY 2022
Quick Ratio 4.8×
FY 2018 5y median 4.8× FY 2022
Debt / Equity 0.2×
FY 2018 5y median 0.0× FY 2022
Net Debt / EBITDA 0.3×
FY 2018 5y median 0.4× FY 2022
Interest Coverage -53.7×
FY 2018 5y median 0.0× FY 2022
Dividends
Dividend Yield 0.0%
FY 2018 5y median 0.0% FY 2022
Payout Ratio 0.0%
FY 2018 5y median 0.0% FY 2022
Annual · latest fiscal year ends 2022-12-31